Novartis slims down with $25bn spin-off of Alcon eyecare business via @FT
https://t.co/zn1agWy74Q— The Propell Group (@ThePropellGroup) June 30, 2018
Novartis slims down with $25bn spin-off of Alcon eyecare business via @FT
https://t.co/zn1agWy74Q— The Propell Group (@ThePropellGroup) June 30, 2018